Learn best practices for starting and running a float center:
  • This field is for validation purposes and should be left unchanged.

 

Looking for something specific?

Search our nearly 100 blog posts.


References

Barnes, M. A., Carson, M. J., & Nair, M. G. (2015). Non-traditional cytokines: How catecholamines and adipokines influence macrophages in immunity, metabolism and the central nervous system. Cytokine72(2), 210–219. https://doi.org/10.1016/j.cyto.2015.01.008

Bluthe, R. M., Pawlowski, M., Suarez, S., Parnet, P., Pittman, Q., Kelley, K. W., & Dantzer, R. (1994). Synergy Between Tumor Necrosis Factor alpha and Interleukin-1 in the Induction of Sickness Behavior in Mice. Psychoneuroendocrinology19(2), 197–207.

Bluthé, R. M., Beaudu, C., Kelley, K. W., & Dantzer, R. (1995). Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats. Brain Research677(1), 171–176. https://doi.org/10.1016/0006-8993(95)00194-U

Bluthe´, R.-M., Dantzer, R., & Kelley, K. W. (1992). Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Research573(2), 318–320. https://doi.org/10.1016/0006-8993(92)90779-9

Capuron, L., Hauser, P., Hinze-Selch, D., Miller, A. H., & Neveu, P. J. (2002). Treatment of cytokine-induced depression. Brain Behavior and Immunity16(5), 575–580. https://doi.org/10.1016/s0889-1591(02)00007-7

Carpenter, L. L., Shattuck, T. T., Tyrka, A. R., Geracioti, T. D., & Price, L. H. (2011). Effect of childhood physical abuse on cortisol stress response. Psychopharmacology214(1), 367–375. https://doi.org/10.1007/s00213-010-2007-4

Cohen, S., Janicki-Deverts, D., Doyle, W. J., Miller, G. E., Frank, E., Rabin, B. S., & Turner, R. B. (2012). Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proceedings of the National Academy of Sciences109(16), 5995–5999. https://doi.org/10.1073/pnas.1118355109

Dantzer, R., Bluthé, R. M., Gheusi, G., Cremona, S., Layé, S., Parnet, P., & Kelley, K. W. (1998). Molecular basis of sickness behavior. Annals of the New York Academy of Sciences856, 132–138. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9917873

Dantzer, R., Bluthe, R. M., & Kelley, K. W. (1991). Androgen-dependent vasopressinergic neurotransmission attenuates interleukin-1-induced sickness behavior. Brain Research557(1–2), 115–120. https://doi.org/10.1016/0006-8993(91)90123-D

Dantzer, R., Wollman, E. E., & Yirmiya, R. (Eds.). (1999). Cytokines, Stess, and Depression. New York, NY: Kluwer Academic / Plenum Publishers.

Davis, K. C., & Raizen, D. M. (2017). A mechanism for sickness sleep: lessons from invertebrates. Journal of Physiology595(16), 5415–5424. https://doi.org/10.1113/JP273009

Dong, J., Li, J., Cui, L., Wang, Y., Lin, J., Qu, Y., & Wang, H. (2018). Cortisol modulates inflammatory responses in LPS-stimulated RAW264.7 cells via the NF-ΚB and MAPK pathways. BMC Veterinary Research14(1), 1–10. https://doi.org/10.1186/s12917-018-1360-0

Dunn, A. J. (2000). Cytokine Activation of the HPA Axis. Annals of the New York Academy of Sciences917(1), 608–617. https://doi.org/10.1111/j.1749-6632.2000.tb05426.x

Fischer, S., Strawbridge, R., Vives, A. H., & Cleare, A. J. (2017). Cortisol as a predictor of psychological therapy response in depressive disorders: Systematic review and meta-analysis. British Journal of Psychiatry210(2), 105–109. https://doi.org/10.1192/bjp.bp.115.180653

Flierl, M. A., Rittirsch, D., Huber-Lang, M., Sarma, J. V., & Ward, P. A. (2008). Catecholamines-crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening pandora’s box? Molecular Medicine (Cambridge, Mass.)14(3–4), 195–204. https://doi.org/10.2119/2007-00105.Flierl

Foley, P., & Kirschbaum, C. (2010). Human hypothalamus-pituitary-adrenal axis responses to acute psychosocial stress in laboratory settings. Neuroscience and Biobehavioral Reviews35(1), 91–96. https://doi.org/10.1016/j.neubiorev.2010.01.010

Irwin, M. R., & Miller, A. H. (2007). Depressive disorders and immunity: 20 years of progress and discovery. Brain, Behavior, and Immunity21(4), 374–383.

Juster, R. P., McEwen, B. S., & Lupien, S. J. (2010). Allostatic load biomarkers of chronic stress and impact on health and cognition. Neuroscience and Biobehavioral Reviews35(1), 2–16. https://doi.org/10.1016/j.neubiorev.2009.10.002

Maier, S. F., & Watkins, L. R. (1998). Cytokines for psychologists – Implications of bidirectional immune-to-brain communication for understanding behaviour, mood and cognition. Physiol. Rev.105(1), 83–107.

Miller, A. H., Pariante, C. M., & Pearce, B. D. (1999). Effects of Cytokines on Glucocorticoid Receptor Expression And Function. Cytokines, Stress, and Depression461, 107–116. https://doi.org/10.1007/978-0-585-37970-8_7

Miller, A. H., & Raison, C. L. (2016). The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nature Reviews Immunology16(1), 22–34. https://doi.org/10.1038/nri.2015.5

Miller, G. E., Chen, E., & Zhou, E. S. (2007). If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychological Bulletin133(1), 25–45.

Miller, G. E., Cohen, S., & Ritchey, A. K. (2002). Chronic psychological stress and the regulation of pro-inflammatory cytokines: A glucocorticoid-resistance model. Health Psychology21(6), 531–541.

Osburg, B., Peiser, C., Dömling, D., Schomburg, L., Ko, Y. T., Voigt, K., & Bickel, U. (2002). Effect of endotoxin on expression of TNF receptors and transport of TNF-alpha at the blood-brain barrier of the rat. American Journal of Physiology – Endocrinology and Metabolism283(5), E899–E908. https://doi.org/10.1152/ajpendo.00436.2001

Pace, T. W. W., & Miller, A. H. (2009). Cytokines and glucocorticoid receptor signaling: Relevance to major depression. Annals of the New York Academy of Sciences1179, 86–105. https://doi.org/10.1111/j.1749-6632.2009.04984.x

Pan, W., Stone, K. P., Hsuchou, H., Manda, V. K., Zhang, Y., & Kastin, A. J. (2011). Cytokine signaling modulates blood-brain barrier function. Current Pharmaceutical Design17(33), 3729–3740. https://doi.org/10.1016/j.molcel.2009.10.020.The

Phelps, C., & Korneva, E. (Eds.). (2008). Cytokine Receptors in the Brain. Amsterdam, The Netherlands: Elsevier B.V. https://doi.org/10.1016/S1567-7443(07)10002-8

Powers, S. I., Laurent, H. K., Gunlicks-Stoessel, M., Balaban, S., & Bent, E. (2016). Depression and anxiety predict sex-specific cortisol responses to interpersonal stress. Psychoneuroendocrinology69, 172–179. https://doi.org/10.1016/j.psyneuen.2016.04.007

Ramer-Quinn, D. S., Baker, R. A., & Sanders, V. M. (1997). Activated T helper 1 and T helper 2 cells differentially express the beta-2-adrenergic receptor: a mechanism for selective modulation of T helper 1 cell cytokine production. Journal of Immunology (Baltimore, Md.: 1950)159(10), 4857–4867. Retrieved from http://www.jimmunol.org/content/159/10/4857%0AWhy

Schoenborn, J. R., & Wilson, C. B. (2007). Regulation of Interferon-γ During Innate and Adaptive Immune Responses. Advances in Immunology96(07), 41–101. https://doi.org/10.1016/S0065-2776(07)96002-2

Segerstrom, S. C., & Miller, G. E. (2004). Psychological Stress and the Human Immune System: A Meta- Analytic Study of 30 Years of Inquiry. Psychological Bulletin130(4), 601–630. https://doi.org/10.1016/j.immuni.2010.12.017.Two-stage

Sehic, E., & Blatteis, C. M. (1996). Blockade of lipopolysaccharide-induced fever by subdiaphragmatic vagotomy in guinea pigs, 726, 160–166.

Shariq, A. S., Brietzke, E., Rosenblat, J. D., Barendra, V., Pan, Z., & McIntyre, R. S. (2018). Targeting cytokines in reduction of depressive symptoms: A comprehensive review. Progress in Neuro-Psychopharmacology and Biological Psychiatry83(October 2017), 86–91. https://doi.org/10.1016/j.pnpbp.2018.01.003

Shonkoff, J. P., Garner, A. S., Siegel, B. S., Dobbins, M. I., Earls, M. F., Garner, A. S., … Wood, D. L. (2012). The Lifelong Effects of Early Childhood Adversity and Toxic Stress. Pediatrics129(1), e232–e246. https://doi.org/10.1542/peds.2011-2663

Skelly, D. T., Hennessy, E., Dansereau, M. A., & Cunningham, C. (2013). A Systematic Analysis of the Peripheral and CNS Effects of Systemic LPS, IL-1Β, TNF-α and IL-6 Challenges in C57BL/6 Mice. PLoS ONE8(7), 1–20. https://doi.org/10.1371/journal.pone.0069123

Sofroniew, M. V. (2015). Astrocyte barriers to neurotoxic inflammation. Nature Reviews Neuroscience16(5), 249–263. https://doi.org/10.1038/nrn3898

Varatharaj, A., & Galea, I. (2016). The blood-brain barrier in systemic inflammation. Brain, Behavior, and Immunity60, 1–12. https://doi.org/10.1016/j.bbi.2016.03.010

Wichmann, S., Kirschbaum, C., Böhme, C., & Petrowski, K. (2017). Cortisol stress response in post-traumatic stress disorder, panic disorder, and major depressive disorder patients. Psychoneuroendocrinology83(January), 135–141. https://doi.org/10.1016/j.psyneuen.2017.06.005

Xaio, H., Banks, W. A., Niehoff, M. L., & Morley, J. E. (2001). Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Research896(1–2), 36–42. https://doi.org/10.1016/S0006-8993(00)03247-9

Zadka, Ł., Dzięgiel, P., Kulus, M., & Olajossy, M. (2017). Clinical Phenotype of Depression Affects Interleukin-6 Synthesis. Journal of Interferon & Cytokine Research37(6), 231–245. https://doi.org/10.1089/jir.2016.0074

Zhou, J., Yan, J., Liang, H., & Jiang, J. (2014). Epinephrine Enhances the Response of Macrophages under LPS Stimulation. BioMed Research International2014, 1–9. https://doi.org/10.1155/2014/254686

2018 Conference Program Introduction

2018 Conference Program Introduction

It was absolutely our pleasure to, once again, host the Float Conference here in Portland. We couldn’t help but be slightly nostalgic remembering all the Conferences we’ve held, all the way back to 2012. Below is the complete introduction for this year’s program intro. While this may be our last year hosting, we look forward to what the rest of the industry has in store for us in the future.

Why we’re Excited for the 2018 Float Conference!

Why we’re Excited for the 2018 Float Conference!

It’s Float On’s final year hosting the Float Conference this year. The wails from all our floaty friends can be heard throughout the galaxy as we mourn the end of an era. But, please, dry your eyes, float industry, because this year is going to be amazing.

There’s absolutely no way we’re not going out with a bang, so buckle up and buy your tickets. We’re planning on making this the best Float Conference yet! We have fresh speakers, amazing activities, new podcasts, and a very full schedule. Everything is going to be bigger and better and the parties are going to be off the hook!

Here’s a little bit from some of us putting this event together about what we’re excited about this year.

Take Part in the 2018 Float Industry Report

Take Part in the 2018 Float Industry Report

We’re gathering responses for our 2018 Industry Report through the end of June, and we once again need your help.

Please take a brief moment to answer a few questions about your float center (or future float center) – it may be the easiest thing you can do to contribute to the growth of floatation around the world.

Achieving Liftoff: Modern Gravity

Achieving Liftoff: Modern Gravity

In another installment of our ongoing series, we’re taking a look at Modern Gravity in Edmonton, Alberta. Matt and J.P., the owners of the center, share what success means to them.   Back in 2013, there wasn’t a single float center near Edmonton, so these guys...

Get Float Mail

Don't Miss a Thing!

Get new blog posts emailed to you.

 
 

Daily Solutions Podcast for float centers

 

Subscribe on iTunes Listen on Google Play Overcast Podcast Player Listen on Spotify Never Miss a Float Tank Solutions Podcast Episode